SCHEMBL17870980

SCHEMBL17870980

c1ccc(CN(Cc2ccccc2)c2ccsn2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.44
HCAR3 P49019 2/20 0.41
TSHR P16473 4/20 0.41
LMNA P02545 3/20 0.39
ADRA2A P08913 2/20 0.39
ADRA2C P18825 2/20 0.39
ADRA1A P35348 2/20 0.39
HRH1 P35367 2/20 0.39
SLC6A3 Q01959 2/20 0.39
KCNH2 Q12809 2/20 0.39
CYP2D6 P10635 2/20 0.39
TAAR1 Q96RJ0 2/20 0.39
PDE4D Q08499 2/20 0.39
CHRM2 P08172 1/20 0.39
ADRA2B P18089 1/20 0.39
DRD1 P21728 1/20 0.39
SLC6A2 P23975 1/20 0.39
HTR2A P28223 1/20 0.39
SLC6A4 P31645 1/20 0.39
OPRK1 P41145 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3728814 0.69 CALM1 (0.46) TSHRLMNAKCNH2TAAR1ALDH1A1
SCHEMBL2960872 0.69 CYP2C19 (0.78) CYP2C19TSHRLMNAADRA2AADRA2C
SCHEMBL43183 0.69 TSHR (0.74) CYP2C19TSHRLMNAADRA2AADRA2C
SCHEMBL28590382 0.68 CHRM2 (0.72) CYP2C19TSHRLMNAADRA2AADRA2C
SCHEMBL355040 0.68 TSHR (0.71) CYP2C19TSHRLMNAADRA2AADRA2C
Hydrochloric Acid SCHEMBL2139953 0.68 TSHR (0.71) CYP2C19TSHRLMNAADRA2AADRA2C
SCHEMBL4973167 0.67 HCAR3 (0.50) CYP2C19HCAR3TSHRLMNAADRA2A
Nitrogen SCHEMBL4599425 0.66 TSHR (0.68) CYP2C19TSHRLMNAADRA2AADRA2C
SCHEMBL9168266 0.65 CYP2C19 (0.59) CYP2C19TSHRLMNAADRA2AADRA2C
SCHEMBL7148219 0.65 TSHR (0.54) CYP2C19TSHRLMNACYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190110476-A1 NOVEL ISOTHIAZOLAMIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-04-18 US disclosed
EP-3236752-A2 NOVEL ISOTHIAZOLAMIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES Bayer CropScience Aktiengesellschaft (DE) 2017-11-01 EP disclosed
WO-2016102435-A2 NOVEL ISOTHIAZOLAMIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190110476-A1 NOVEL ISOTHIAZOLAMIDES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES CYP4Z1, CYP51A1, CBR3 CYP2C19 60/4885HCAR3 1792/4885TSHR 2734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.